Literature DB >> 10851052

IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.

E P Reddy1, A Korapati, P Chaturvedi, S Rane.   

Abstract

Hematopoiesis is the cumulative result of intricately regulated signal transduction cascades that are mediated by cytokines and their cognate receptors. Proper culmination of these diverse signaling pathways forms the basis for an orderly generation of different cell types and aberrations in these pathways is an underlying cause for diseases such as cancer. Over the past several years, downstream events initiated upon cytokine/growth factor stimulation have been a major focus of biomedical research. As a result, several key concepts have emerged allowing a better understanding of the complex signaling processes. A group of novel transcription factors, termed signal transducers and activators of transcription (STATs) appear to orchestrate the downstream events propagated by cytokine/growth factor interactions with their cognate receptors. Until recently, the JAK proteins were considered to be the tyrosine kinases, which dictated the levels of phosphorylation and activation of STAT proteins, forming the basis of the JAK-STAT model. However, over the past few years, increasing evidence has accumulated which indicates that at least some of the STAT protein activation may be mediated by members of the Src gene family following cytokine/growth factor stimulation. Studies have demonstrated that the Src-family of tyrosine kinases can phosphorylate and activate certain STAT proteins, in lieu of JAK kinases. In such a scenario, JAK kinases may be more crucial to phosphorylation of the cytokine/growth factor receptors and in the process create docking sites on the receptors for binding of SH2-containing proteins such as STATs, Src-kinases and other signaling intermediates. Tyrosine phosphorylation and activation of STAT proteins can be achieved either by JAKs or Src-kinases depending on the nature of STAT that is being activated. This forms the basis for the JAK-Src-STAT model proposed in this review. The concerted action of JAK kinases, members of the Src-kinase family and STAT proteins, leads to cell proliferation and cell survival, the end-point of the cytokine/growth factor stimulus. Oncogene (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851052     DOI: 10.1038/sj.onc.1203594

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  69 in total

Review 1.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 4.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

5.  Phosphorylation-mediated activation of mouse Xkr8 scramblase for phosphatidylserine exposure.

Authors:  Takaharu Sakuragi; Hidetaka Kosako; Shigekazu Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

6.  Distinct signaling programs control human hematopoietic stem cell survival and proliferation.

Authors:  David J H F Knapp; Colin A Hammond; Nima Aghaeepour; Paul H Miller; Davide Pellacani; Philip A Beer; Karen Sachs; Wenlian Qiao; WeiJia Wang; R Keith Humphries; Guy Sauvageau; Peter W Zandstra; Sean C Bendall; Garry P Nolan; Carl Hansen; Connie J Eaves
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

7.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

Authors:  Agata Klejman; Steven J Schreiner; Malgorzata Nieborowska-Skorska; Artur Slupianek; Matthew Wilson; Thomas E Smithgall; Tomasz Skorski
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

Review 8.  Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.

Authors:  Daniel G Guy; Geoffrey L Uy
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

9.  STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta.

Authors:  Min Xu; Lei Nie; Seung-Hwan Kim; Xiao-Hong Sun
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival.

Authors:  Emma F Barry; Fernando A Felquer; Jason A Powell; Lisa Biggs; Frank C Stomski; Andrea Urbani; Hayley Ramshaw; Peter Hoffmann; Matthew C Wilce; Michele A Grimbaldeston; Angel F Lopez; Mark A Guthridge
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.